Anais Brasileiros de Dermatologia

ISSN: 0365-0596

Anais Brasileiros de Dermatologia is the official scientific publication of the Brazilian Society of Dermatology (SBD - Sociedade Brasileira de Dermatologia). The journal has been published since 1925.

It is a bimonthly open access peer-reviewed journal devoted to the dissemination of studies, evidence and technical-scientific reports that are original and unpublished, results from research, reviews or communications about dermatology and related fields.

The journal is focused on Tropical Dermatology, Parasitic and Infectious Dermatology, STDs/AIDS and Dermopathology.

The opinions and statements contained in the journal are the sole and exclusive responsibility of their authors, and do not necessarily coincide with those of the Editorial Staff, the Advisory Board or the Brazilian Society of Dermatology.

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), Science Citation Index Expanded (SCIE), SCImago Journal Rank (SJR), SNIP

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

Impact factor 2024

3.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2024

2.5

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2024

0.585

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2024

0.995

View more metrics

Open Access Option

Journal Information

Special content about coronavirus SARS-CoV-2 (COVID-19) in Anais Brasileiros de Dermatologia

Lipschütz ulcers after AstraZeneca COVID-19 vaccination

Maria Bracho-Borro, Graciela Guzmán-Perera, Mario Magaña

10.1016/j.abd.2022.09.010

Full text access

Twitter

Facebook

Meyerson nevus triggered by COVID-19

Rubén Linares-Navarro, Pedro Sánchez-Sambucety, Manuel Ángel Rodríguez-Prieto

10.1016/j.abd.2022.11.002

Full text access

Twitter

Facebook

Cutaneous manifestations of COVID-19 patients in a Hospital in São Paulo, Brazil, and global literature review

Silmara da Costa Pereira Cestari, Marcela da Costa Pereira Cestari, Gabriela Franco Marques, Ivana Lirio, Reinaldo Tovo, Ilana Cruz Silva Labriola

10.1016/j.abd.2022.09.007

Full text access

Twitter

Facebook

Perniosis-like erythema after SARS-CoV2 infection reactivated by vaccination with inactivated virus

Lucas Campos Garcia, Vanessa Martins Barcelos, Myrciara Macedo de Alcântara, Priscila Jordana Costa Valadares

10.1016/j.abd.2022.01.015

Full text access

Twitter

Facebook

COVID-19 infection and vaccines: potential triggers of Herpesviridae reactivation

Alba Navarro-Bielsa, Tamara Gracia-Cazaña, Beatriz Aldea-Manrique, Isabel Abadías-Granado, Adrián Ballano, Isabel Bernad, Yolanda Gilaberte

10.1016/j.abd.2022.09.004

Full text access

Twitter

Facebook

Morphea after SARS-CoV2 vaccine

Giovanni Paolino, Matteo Riccardo Di Nicola, Nathalie Rizzo, Santo Raffaele Mercuri

10.1016/j.abd.2022.04.010

Full text access

Twitter

Facebook

Post-COVID-19 lichen planus annularis: report of a rare association

Laura Murari Mondadori, Helena Barbosa Lugão, Fernanda André Martins Cruz Perecin, Marco Andrey Cipriani Frade

10.1016/j.abd.2021.10.016

Full text access

Twitter

Facebook

Dermatologic manifestations of multisystem inflammatory syndrome in children during the COVID-19 pandemic

Leyla Baykal Selçuk, Arzu Ferhatosmanoğlu, Zeynep Gökçe Gayretli Aydın, Deniz Aksu Arıca, Osman Yeşilbaş

10.1016/j.abd.2022.08.003

Open access

Twitter

Facebook

Did COVID-19 lockdown delay actually worsen melanoma prognosis?

Pedro Gil-Pallares, Olalla Figueroa-Silva, Maria Eugenia Gil-Pallares, José Ángel Vázquez-Bueno, Francisca Piñeyro-Molina, Benigno Monteagudo, Cristina De las Heras-Sotos

10.1016/j.abd.2022.08.004

Open access

Twitter

Facebook

Impact of COVID-19 pandemic on the course of refractory chronic spontaneous urticaria under omalizumab treatment

Müge Olgaç, Osman Ozan Yeğit, Şengül Beyaz, Nida Öztop, Can Tüzer, Deniz Eyice, Pelin Karadağ, Raif Coşkun, Semra Demir, Bahaauddin Çolakoğlu, Suna Büyüköztürk, Aslı Gelincik

10.1016/j.abd.2022.08.006

Open access

Twitter

Facebook

Previous 1 Page 2 3 4 Next

Indexed in:

Follow us:

Subscribe:

Special content about coronavirus SARS-CoV-2 (COVID-19) in Anais Brasileiros de Dermatologia

Subscribe to our newsletter